Daniel Elger, previously vice president of marketing and communications at Antisoma Plc, has been appointed chief financial officer and member of the board at e-Therapeutics Plc. This follows the departure of JM Cordiner, finance director, who is leaving the company to pursue other interests.
Dr Elger, who holds a PhD in cancer cell biology from Oxford University, was a member of Antisoma’s senior management team from 2005. He joined that company in 2002.
Copyright 2011 Evernow Publishing Ltd